Beverly Hills, CANCT05890352Now EnrollingIRB Ready

Large B-Cell Lymphoma Clinical Trial in Beverly Hills, CA

Access cutting-edge large b-cell lymphoma treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.

Sponsored by SWOG Cancer Research Network

Quick Self-Assessment

See if you qualify for this Beverly Hills location

Preparing your pre-screening questions...

Expert Care in Beverly Hills

Access large b-cell lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related large b-cell lymphoma treatment provided free

Apply for This Beverly Hills Location

Check if you qualify for this large b-cell lymphoma clinical trial in Beverly Hills, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Beverly Hills

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Beverly Hills site if eligible
  4. 4Begin participation

About This Large B-Cell Lymphoma Study in Beverly Hills

This phase 2 trial studies the side effects and best dose of tazemetostat and zanubrutinib in combination with tafasitamab and lenalidomide, and to see how well these combinations work in treating patients with large B-cell lymphoma that returned or did not respond to earlier treatment. Tazemetostat is in a class of medications called EZH2 inhibitors. It helps to stop the spread of cancer cells. Zanubrutinib is in a class of medications called kinase inhibitors. It works by blocking the action o

Sponsor: SWOG Cancer Research Network

Who Can Participate

Inclusion Criteria

Participants must have:
Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines
Follicular lymphoma, grade 3B
Transformed lymphoma
High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangements
Participants must have staging imaging performed within 28 days prior to registration, as follows. Positron emission tomography (PET)-computed tomography (CT) baseline scans are strongly preferred; diagnostic quality magnetic resonance imaging (MRI), contrast-enhanced CT, or contrast-enhanced MRI scans are also acceptable if PET-CT is not feasible at baseline. Note: PET-CT will be required at end of treatment (EOT) and progression for response assessment. All measurable lesions (longest diameter \>= 1.5 cm) must be assessed within 28 days prior to registration. Tests to assess non-measurable disease must be performed within 28 days prior to registration. All disease must be document

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Beverly Hills?

Yes, this clinical trial (NCT05890352) has an active research site in Beverly Hills, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Large B-Cell Lymphoma Treatment Options in Beverly Hills, CA

If you're searching for large b-cell lymphoma treatment options in Beverly Hills, CA, this clinical trial (NCT05890352) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all large b-cell lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Beverly Hills, CA

See all lymphoma clinical trials recruiting in Beverly Hills — not just this study.

Browse Lymphoma Trials in Beverly Hills

Ready to Join in Beverly Hills?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Beverly Hills, CA